I am a
Home I AM A Search Login

Papers of the Week

Papers: 23 Jan 2021 - 29 Jan 2021

Pharmacology/Drug Development


2021 Jan 25

J Neurol Neurosurg Psychiatry

Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects.


Ray J C, Kapoor M, Stark RJ, Wang S-J, Bendtsen L, Matharu M, Hutton E J
J Neurol Neurosurg Psychiatry. 2021 Jan 25.
PMID: 33495299.


Migraine is the second largest cause of years lost to disability globally among all diseases, with a worldwide prevalence over 1 billion. Despite the global burden of migraine, few classes of therapeutics have been specifically developed to combat migraine. After 30 years of translational research, calcitonin gene-related peptide (CGRP) inhibitors have emerged as a promising new tool in the prevention of migraine. Like all new therapeutics; however, we have limited real-world experience and CGRP has several known systemic actions that warrant consideration. This article provides a narrative review of the evidence for CGRP antagonists and summarises the known and potential side effects that should be considered.